Floxipro

Floxipro 500 mg film-coated tablets are indicated for the treatment of the following infections. Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Adults
Lower respiratory tract infections due to Gram-negative bacteria

COPD exacerbations

Broncho-pulmonary infections in cystic fibrosis or in bronchiectasis

Pneumonia

Chronic suppurative otitis media

Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria

Urinary tract infections

Gonococcal uretritis and cervicitis

Epididymo-orchitis including cases due to Neisseria gonorrhoeae

Pelvic inflammatory disease including cases due to Neisseria gonorrhoeae

In the above genital tract infections when thought or known to be due to Neisseria gonorrhoeae it is particularly important to obtain local information on the prevalence of resistance to ciprofloxacin and to confirm susceptibility based on laboratory testing.

Infections of the gastro-intestinal tract (e.g. travellers’ diarrhoea)

Intra-abdominal infections

Infections of the skin and soft tissue caused by Gram-negative bacteria

Malignant external otitis

Infections of the bones and joints

Treatment of infections in neutropenic patients & Prophylaxis of infections in neutropenic patients

Inhalation anthrax (post-exposure prophylaxis and curative treatment)

Children and adolescents

Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa

Complicated urinary tract infections and pyelonephritis

Inhalation anthrax (post-exposure prophylaxis and curative treatment)

Floxipro may also be used to treat severe infections in children and adolescents when this is considered to be necessary.

Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.

Dose:

Ask your Doctor